In 2022, over four million Canadians, or 10% of the population, were estimated to be living with diabetes, which Read More
OPTITHERA, ELNA, and Génome Québec partner on genetic test for type 2 diabetes
Last week, Better Therapeutics, a company developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, and diabetes management Read More